High-Content Imaging Resource Center

High-content imaging (HCI) is a powerful technique that combines automated fluorescence microscopy with advanced image analysis. It provides information-rich insights into multiple cellular processes at the scale needed to keep drug discovery programs moving forward. HCI uses high-resolution optics and robotic plate handling to simultaneously quantify changes in protein expression, organelle morphology, and cellular phenotypes across thousands of samples. 

Traditional fluorescence microscopy is typically low-throughput and manual, while high-content imaging (HCI) uses automated fluorescence microscopy to capture thousands of data points in a high-throughput manner. Due to the sheer scale of data generated per assay, HCI utilizes advanced image analysis methods to streamline data processing. 

A robust HCI workflow requires high-performance staining reagents, starting with highly specific primary antibodies. These can be directly conjugated to photostable fluorophores for streamlined multiplexing or paired with signal-amplifying secondary antibodies. Organelle and cytoskeletal dyes are often used to complement the target-specific antibodies with important contextual information.

All CST antibodies validated for immunofluorescent-immunocytochemistry (IF-IC) are inherently optimized for high-content imaging (HCI) and high-content screening (HCS), providing the desired high signal-to-noise ratios and exceptional specificity required to generate accurate imaging data.

Highly specific antibodies minimize non-specific background binding, providing the clear contrast required for automated image analysis. Without this specificity, the analysis software cannot accurately separate the target signal from background noise, compromising segmentation and quantification accuracy.

Cell Painting is a high-content, morphological profiling assay that utilizes a standardized set of six fluorescent dyes to label eight distinct cellular components. While this dye-based approach is useful for broad phenotypic screening and detecting subtle morphological changes, it is unable to pinpoint the specific proteins or signaling pathways involved. Therefore, the use of antibody reagents is essential as a targeted follow-up to obtain mechanistic data that dyes alone cannot capture. Integrating antibody-based high-content assays into drug discovery programs allows researchers to transition from phenotypic observations to protein-level insights.

High-content imaging (HCI) involves acquiring images using automated microscopy to capture detailed cellular images, while high-content analysis (HCA) transforms those images into quantitative data using sophisticated algorithms that measure features like intensity, texture, and spatial localization. Combined, HCI and HCA enable high-content screening (HCS), an approach that can be used to analyze large-scale libraries of hundreds to millions of compounds.

High-Throughput Methods to Quantitatively Evaluate TGF-β Signaling in Angiogenesis

High-Throughput Methods to Quantitatively Evaluate TGF-β Signaling in Epithelial-to Mesenchymal Transitions

Webinar: A Multiscale Approach to Quantitatively Evaluate SMAD Signaling

Poster Presentation Video: A Multiscale Approach to Quantitatively Evaluate the SMAD Signaling Pathway

A Multiscale Approach to Quantitatively Evaluate the SMAD Signaling Pathway

Quantitative evaluation of biomarkers for TGF-β-induced epithelial-mesenchymal transition in biochemical, cellular, and 3D spheroid model systems

Microglial Activation: High-Content Immunofluorescence to Study TREM2 Signaling

High-Throughput 3D Assay Methods: Analysis of TGF-β Signaling